| Code: MTA14353 | Publication Date: Oct 2026 |
The following is a data-backed list of the leading Uveal Melanoma Treatment companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. Merck & Co., Novartis AG currently lead the competitive landscape, alongside several other established players shaping the Global Uveal Melanoma Treatment Market.
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Uveal Melanoma Treatment Market.
| Company Name | Merck & Co. |
|---|---|
| Established Year | 1891 |
| Headquarters | Rahway, New Jersey, United States |
| Official Website | Click Here |
Merck & Co. is a leading global healthcare titan driving innovation through life-saving prescription medicines, vaccines, biologic therapies, and revolutionary oncology treatments like Keytruda.
| Company Name | Novartis AG |
|---|---|
| Established Year | 1996 |
| Headquarters | Basel, Switzerland |
| Official Website | Click Here |
Novartis AG is a premier global medicines company utilizing advanced science and digital technologies to create innovative treatments in core therapeutic areas, including oncology, immunology, and neuroscience.
| Company Name | Immunocore Holdings plc |
|---|---|
| Established Year | 2008 |
| Headquarters | Abingdon, Oxfordshire, United Kingdom |
| Official Website | Click Here |
Immunocore Holdings is a commercial-stage biotechnology pioneer developing a novel class of bi-specific T cell receptor-based immunotherapies (ImmTACs) designed to treat cancer and infectious diseases.
| Company Name | IDEAYA Biosciences |
|---|---|
| Established Year | 2015 |
| Headquarters | South San Francisco, California, United States |
| Official Website | Click Here |
IDEAYA Biosciences is a precision medicine oncology company committed to the discovery and development of targeted therapeutics utilizing synthetic lethality for biomarker-defined cancer patient populations.
| Company Name | Delcath Systems, Inc. |
|---|---|
| Established Year | 1988 |
| Headquarters | New York, New York, United States |
| Official Website | Click Here |
Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers through its proprietary Hepatic CHEMOSAT Delivery System.
| Company Name | Aura Biosciences |
|---|---|
| Established Year | 2009 |
| Headquarters | Boston, Massachusetts, United States |
| Official Website | Click Here |
Aura Biosciences is a clinical-stage biotechnology company developing a novel class of targeted oncology therapies based on virus-like drug conjugates (VDCs) for precision ocular and solid tumor cancers.
| Company Name | AstraZeneca Plc. |
|---|---|
| Established Year | 1999 |
| Headquarters | Cambridge, United Kingdom |
| Official Website | Click Here |
AstraZeneca is a global, science-led biopharmaceutical corporation specializing in the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and cardiovascular, renal, and metabolic conditions.
| Company Name | iOnctura SA |
|---|---|
| Established Year | 2017 |
| Headquarters | Geneva, Switzerland |
| Official Website | Click Here |
iOnctura SA is a clinical-stage biopharmaceutical enterprise dedicated to developing selective small molecule therapeutics that simultaneously target tumor survival pathways and immune-evasion mechanisms within the tumor microenvironment.
ISO 9001:2015 CERTIFIED
Quality Management System for market research & advisory services
Cert. No. 3050261008135Q